These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 35413335

  • 1. Fashionably late: A characterization of late coagulopathies in rattlesnake envenomations between Fab and F(ab')2 antivenoms.
    Dudley S, Smelski G, Massey DJ, Maciulewicz T, Cardwell MD, Shirazi FM.
    Toxicon; 2022 Jun; 212():49-54. PubMed ID: 35413335
    [Abstract] [Full Text] [Related]

  • 2. Comparison of F(ab')2 and Fab antivenoms in rattlesnake envenomation: First year's post-marketing experience with F(ab')2 in New Mexico.
    Mascarenas DN, Fullerton L, Smolinske SC, Warrick BJ, Seifert SA.
    Toxicon; 2020 Oct 30; 186():42-45. PubMed ID: 32763251
    [Abstract] [Full Text] [Related]

  • 3. Initial Experience with F(ab')2 Antivenom Compared with Fab Antivenom for Rattlesnake Envenomations Reported to a single poison center during 2019.
    Wilson BZ, Bahadir A, Andrews M, Karpen J, Winkler G, Smelski G, Dudley S, Walter FG, Shirazi FM.
    Toxicon; 2022 Apr 15; 209():10-17. PubMed ID: 35085602
    [Abstract] [Full Text] [Related]

  • 4. Subacute coagulopathy in a randomized, comparative trial of Fab and F(ab')2 antivenoms.
    Boyer LV, Chase PB, Degan JA, Figge G, Buelna-Romero A, Luchetti C, Alagón A.
    Toxicon; 2013 Nov 15; 74():101-8. PubMed ID: 23948058
    [Abstract] [Full Text] [Related]

  • 5. Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial.
    Bush SP, Ruha AM, Seifert SA, Morgan DL, Lewis BJ, Arnold TC, Clark RF, Meggs WJ, Toschlog EA, Borron SW, Figge GR, Sollee DR, Shirazi FM, Wolk R, de Chazal I, Quan D, García-Ubbelohde W, Alagón A, Gerkin RD, Boyer LV.
    Clin Toxicol (Phila); 2015 Jan 15; 53(1):37-45. PubMed ID: 25361165
    [Abstract] [Full Text] [Related]

  • 6. Pediatric Rattlesnake Envenomations Treated With Crotalidae Equine Immune F(Ab') 2 Antivenom : A 3-Year Retrospective Observational Analysis.
    Seltzer JA, Winkler GA, Friedman NA, Galust H, Hardin J, Srihari P, Ontiveros S, Corbett B, Clark RF.
    Pediatr Emerg Care; 2023 Oct 01; 39(10):776-779. PubMed ID: 37725768
    [Abstract] [Full Text] [Related]

  • 7. Late hemotoxicity following North American rattlesnake envenomation treated with crotalidae immune F(ab')2 (equine) antivenom and crotalidae immune polyvalent Fab (ovine) antivenom reported to the North American Snakebite Sub-registry.
    Spyres MB, Padilla GK, Gerkin RD, Hoyte CO, Wolk BJ, Ruha AM, ToxIC Snakebite Study Group.
    Clin Toxicol (Phila); 2022 Jul 01; 60(7):838-842. PubMed ID: 35261320
    [Abstract] [Full Text] [Related]

  • 8. Early Experience with Crotalidae Immune F(ab')2 Antivenom to Treat Arizona Rattlesnake Envenomations.
    Ruha AM, Padilla-Jones A, Canning J, Spyres MB, Curry SC.
    J Med Toxicol; 2022 Jan 01; 18(1):38-42. PubMed ID: 34665424
    [Abstract] [Full Text] [Related]

  • 9. Coagulation parameters in copperhead compared to other Crotalinae envenomation: secondary analysis of the F(ab')2 versus Fab antivenom trial.
    Gerardo CJ, Vissoci JR, Brown MW, Bush SP.
    Clin Toxicol (Phila); 2017 Feb 01; 55(2):109-114. PubMed ID: 27806644
    [Abstract] [Full Text] [Related]

  • 10. Unpredicted late-, new-onset thrombocytopenia and hypofibrinogenemia in Fab antivenom-treated rattlesnake envenomation.
    Seifert SA, Mascarenas DN, Fullerton L, Warrick BJ, Smolinske SC.
    Toxicon; 2020 Sep 01; 184():55-56. PubMed ID: 32505639
    [Abstract] [Full Text] [Related]

  • 11. Characterization of hypofibrinogenemia following rattlesnake envenomation treated with crotalidae immune F(ab')2 (equine) antivenom.
    Maciulewicz TS, Axon DR, Shirazi FM.
    Clin Toxicol (Phila); 2024 Nov 01; 62(11):749-753. PubMed ID: 39318272
    [Abstract] [Full Text] [Related]

  • 12. Rattlesnake venom-induced recurrent coagulopathy in first trimester pregnant women - Two Cases.
    Moore EC, Porter LM, Ruha AM.
    Toxicon; 2019 May 01; 163():8-11. PubMed ID: 30880187
    [Abstract] [Full Text] [Related]

  • 13. Delayed hematologic toxicity following rattlesnake envenomation unresponsive to crotalidae polyvalent antivenom.
    Bailey AM, Justice S, Davis GA, Weant K.
    Am J Emerg Med; 2017 Jul 01; 35(7):1038.e1-1038.e2. PubMed ID: 28259369
    [Abstract] [Full Text] [Related]

  • 14. Total CroFab and Anavip Antivenom Vial Administration in US Rattlesnake Envenomations: 2019-2021.
    Brandehoff N, Dalton A, Daugherty C, Dart RC, Monte AA, ToxIC Snakebite Study Group.
    J Med Toxicol; 2023 Jul 01; 19(3):248-254. PubMed ID: 37115482
    [Abstract] [Full Text] [Related]

  • 15. Use of both Fab and F(ab')2 fragment antivenom in a pediatric patient for treatment of a North American Crotalidae envenomation.
    Martin AM, Wang GS, Poel K.
    Am J Emerg Med; 2021 Jul 01; 45():677.e1-677.e3. PubMed ID: 33293188
    [Abstract] [Full Text] [Related]

  • 16. Use of Crotalidae equine immune F(ab')2 antivenom for treatment of an Agkistrodon envenomation.
    Wilson BZ, Larsen J, Smelski G, Dudley S, Shirazi FM.
    Clin Toxicol (Phila); 2021 Nov 01; 59(11):1023-1026. PubMed ID: 33703984
    [Abstract] [Full Text] [Related]

  • 17. 272 cases of rattlesnake envenomation in dogs: Demographics and treatment including safety of F(ab')2 antivenom use in 236 patients.
    Witsil AJ, Wells RJ, Woods C, Rao S.
    Toxicon; 2015 Oct 01; 105():19-26. PubMed ID: 26341419
    [Abstract] [Full Text] [Related]

  • 18. Continuous IV Crotalidae Polyvalent Immune Fab (Ovine) (FabAV) for selected North American rattlesnake bite patients.
    Bush SP, Seifert SA, Oakes J, Smith SD, Phan TH, Pearl SR, Reibling ET.
    Toxicon; 2013 Jul 01; 69():29-37. PubMed ID: 23474267
    [Abstract] [Full Text] [Related]

  • 19. Recurrent and persistent coagulopathy following pit viper envenomation.
    Boyer LV, Seifert SA, Clark RF, McNally JT, Williams SR, Nordt SP, Walter FG, Dart RC.
    Arch Intern Med; 1999 Apr 12; 159(7):706-10. PubMed ID: 10218750
    [Abstract] [Full Text] [Related]

  • 20. Comparative study of the efficacy and safety of two polyvalent, caprylic acid fractionated [IgG and F(ab')2] antivenoms, in Bothrops asper bites in Colombia.
    Otero-Patiño R, Segura A, Herrera M, Angulo Y, León G, Gutiérrez JM, Barona J, Estrada S, Pereañez A, Quintana JC, Vargas LJ, Gómez JP, Díaz A, Suárez AM, Fernández J, Ramírez P, Fabra P, Perea M, Fernández D, Arroyo Y, Betancur D, Pupo L, Córdoba EA, Ramírez CE, Arrieta AB, Rivero A, Mosquera DC, Conrado NL, Ortiz R.
    Toxicon; 2012 Feb 12; 59(2):344-55. PubMed ID: 22146491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.